Skip to main content
SpringerLink
Log in

Ad26.cov2-s

Fatigue, fever and hypertensive crisis: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Reimann P, et al. Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response. British Journal of Haematology 196: 577-584, No. 3, Feb 2022. Available from: URL: http://doi.org/10.1111/bjh.17982

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ad26.cov2-s. Reactions Weekly 1898, 23 (2022). https://doi.org/10.1007/s40278-022-11616-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-11616-x

Search

Navigation